| Financial Year |
March 31 2023 |
| Monetary Funds |
303,380,266.21 |
| Held-for-trading Financial Assets |
120,941,315.86 |
| Notes Receivable |
73,049,927.47 |
| Accounts Receivable |
198,561,517.66 |
| Advances to Suppliers |
3,700,000.92 |
| Other Receivables |
217,202.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
461,981,380.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,940,621.42 |
| Total Current Assets |
1,255,156,387.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
384,756,136.58 |
| Under-construction Projects |
120,782,684.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,511,521.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
13,089,913.96 |
| Other Non-Current Assets |
93,882,720.63 |
| Sub-Total of Non-Current Assets |
753,076,796.02 |
| Total Assets |
2,008,233,183.85 |
| Short-Term Loans |
97,389,768.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
132,376,706.04 |
| Accounts Payable |
60,017,624.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,502,751.92 |
| Taxes Payable |
16,489,824.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,863,001.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,328,637.32 |
| Other Current Liabilities |
2,793,256.99 |
| Sub-Total of Current Liabilities |
337,454,906.01 |
| Long-term Loans |
50,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,724,668.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
94,373,946.60 |
| Total Liabilities |
431,828,852.61 |
| Paid-In Capital(Or Share Stock) |
302,010,000.00 |
| Capital Surplus |
543,096,818.99 |
| Surplus Reserve |
78,974,543.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
650,645,351.05 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,576,404,331.24 |
| Owner's Equity（Stockholder's Equity） |
1,576,404,331.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,008,233,183.85 |
